Bio-Rad Laboratories Inc. (BIO)
NYSE
Closed
Oct 7, 2026
Day's Range
363.9852 wk Range
236.73Overview - BIO - Bio-Rad Laboratories Inc.
Key Statistics
Valuation
Enterprise Value
9.62B
P/E (Trailing)
‪44.96‬
P/E (Forward)
‪37.22‬
PEG Ratio
‪2.36‬
Price / Sales (TTM)
‪3.81‬
Price / Book
‪1.37‬
EV / EBITDA
‪21.81‬
Profitability
Gross Margin
‪53.11%‬
Profit Margin
‪8.58%‬
Operating Margin
‪11.18%‬
Return on Assets
‪1.66%‬
Return on Equity
‪3.11%‬
Ownership
Shares Outstanding
26.73M
Float
21.35M
Short % of Shares Outstanding
‪6.28%‬
Held by Insiders
‪16.40%‬
Held by Institutions
‪91.58%‬
Price stats
Beta
‪1.07‬
50-Day Avg
‪364.59‬
200-Day Avg
‪307.42‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Average price target
‪$ 329.00‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BIO - Bio-Rad Laboratories Inc.
Peers - BIO - Bio-Rad Laboratories Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- BIONYSEBio-Rad Laboratories Inc.9.87BMarket Cap+16.25%52-week change44.96P/E (Trailing)‪8.58%‬Profit Margin
- CVXNYSEChevron Corporation406.24BMarket Cap+25.86%52-week change19.95P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories169.82BMarket Cap-37.17%52-week change31.55P/E (Trailing)‪11.64%‬Profit Margin
- MDTNYSEMedtronic plc110.49BMarket Cap-13.95%52-week change21.28P/E (Trailing)‪13.93%‬Profit Margin
- SYKNYSEStryker Corp.105.64BMarket Cap-32.98%52-week change28.32P/E (Trailing)‪14.43%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.84.29BMarket Cap-5.93%52-week change21.39P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corp.61.73BMarket Cap-127.00%52-week change17.25P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - BIO - Bio-Rad Laboratories Inc.
About
Bio-Rad Laboratories Inc. is a life sciences and clinical diagnostics company that develops, manufactures, and markets products used in research laboratories, biopharmaceutical workflows, and healthcare testing. Bio-Rad Laboratories Inc. serves two main business segments: Life Science and Clinical Diagnostics. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
